Document Detail

Primary splenic hairy cell leukaemia: a case report and review of the literature.
MedLine Citation:
PMID:  3319677     Owner:  NLM     Status:  MEDLINE    
Hairy cell leukaemia affecting primarily the spleen is a very rare feature of this disease at presentation. Splenectomy in such cases would seem to provide a cure. We report a case of primary splenic hairy cell leukaemia in which clinical and haematological remission were achieved after splenectomy, and we review the literature.
J P Ng; R B Hogg; R L Cumming; J McCallion; D Catovsky
Related Documents :
24871517 - Taxonomic notes on ochlerus: revisiting herrich-schäffer's species (hemiptera: pentat...
3319677 - Primary splenic hairy cell leukaemia: a case report and review of the literature.
12048637 - A case of hyperplastic polyposis of the colon with adenocarcinomas in hyperplastic poly...
8328427 - Acupuncture and blood studies in sickle-cell anemia.
7892057 - Miliary tuberculosis with splenic rupture: a fatal case with hemophagocytic syndrome an...
25238167 - Adenocarcinoma in situ of the uterine cervix-a systematic review.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  European journal of haematology     Volume:  39     ISSN:  0902-4441     ISO Abbreviation:  Eur. J. Haematol.     Publication Date:  1987 Oct 
Date Detail:
Created Date:  1988-02-20     Completed Date:  1988-02-20     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8703985     Medline TA:  Eur J Haematol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  349-52     Citation Subset:  IM    
Department of Haematology, Stobhill General Hospital, Glasgow, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Cell Count
Leukemia, Hairy Cell / pathology*,  therapy
Middle Aged
Spleen / pathology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Danazol in the treatment of myelodysplastic syndromes.
Next Document:  Immunological reclassification of 22 children with a former diagnosis of non-T, non-B ALL.